These results suggest that auranofin may display its anticancer effect through downregulation of IKK-β, which then triggers the translocation of the FOXO3 protein from the cytoplasm into the nucleus of ovarian cancer cells. This evidence concerns the gene FOXO3 and ovarian cancer.